Hanmi established license contract of diabetes treatments with Sanofi for EUR 400 million

Hanmi Pharm announced on the 5^th that Sanofi established a license contract for the Quantum Project, a portfolio of long-acting diabetes new drugs, which has been developed by Hanmi Pharm.

Under the term of the agreement, Hanmi Pharm will receive an upfront payment of EUR 400 million and phased milestones of EUR 3.5 billion in development, registration and sales. After their commercialization,...